Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: accounts (204), files (83), paperwork (33)

Carboplatin (AUC4)-Gemcitabine (day 1, 8) Retreat

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1, 8) Retreat Indication • Recurrent
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday18Retreat.pdf

Bevacizumab (15) Carboplatin-Paclitaxel (21 day)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC5)-PACLITAXEL (21 day) Regimen • Cervix-Bevacizumab (15)-Carboplatin (AUC5)-Paclitaxel (21 day) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Cervical-cancer/Bevacizumab-15-Carboplatin-Paclitaxel-21-day.pdf

Carboplatin (AUC4)-Gemcitabine (day 1) Retreat

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1) Indication • Recurrent platinum sensitive ovarian
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday1Retreat.pdf

Carboplatin(AUC5)-Paclitaxel_7day

Description: Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC 5)-PACLITAXEL(7 day) Regimen • Breast-Carboplatin (AUC 5)-Paclitaxel (7 day) Indication • Neo-adjuvant
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/CarboplatinAUC5-Paclitaxel-7day.pdf

AAA screening leaflet - Public Health England

Description: Chest Heart Aorta with an aneurysm Abdomen Abdominal aortic aneurysm (AAA) screening A free NHS check for men aged 65 an
Url: /Media/UHS-website-2019/Docs/Services/Blood-heart-and-circulation/AAA-screening-leaflet-Public-Health-England.pdf

Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel(14) Ver1

Description: Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXELACCELERATED Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel (accelerated) Indication • Neoadjuvant / adjuvant therapy of early breast
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Accelerated-Cyclophosphamide-Epirubicin-Paclitaxel-14.pdf

RIPCORD Privacy Notice UHS v5

Description: This is a PRIVACY NOTICE for patients who took part in the RIPCORD 2 study Chief Investigator: Professor Nicholas Curzen, University
Url: /Media/Southampton-Clinical-Research/Downloads/RIPCORD-Privacy-Notice-UHS-v5.pdf

Colorectal radiotherapy - patient information

Description: This factsheet explains what colorectal radiotherapy is and what to expect during treatment.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Colorectal-radiotherapy-1316-PIL.pdf

Female pelvis radiotherapy - patient information

Description: This factsheet explains what to expect during your radiotherapy treatment to the female pelvis.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Female-pelvis-radiotherapy-1415-PIL.pdf

Leg amputation - patient information

Description: Information about leg amputation surgery, performed as an absolute last resort for poor blood flow to your leg, or a serious
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Leg-amputation-1661-PIL.pdf

521 to 530 of 570

Previous … 51 52 53 54 55 … Next